Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Budesonide inhaler

Suspend budesonide in step 1 while mixing. Homogenize for 10 minutes. [Pg.94]

On quality control release, fill the suspension, 2.582 g in aluminum containers. [Pg.94]

Crimp the valve and pressurize with the mixture of dichlorodifluoromethane and dichlorotet-rafluoromethane, 4.118 g per container. [Pg.94]

Smaldone GC, McKenzie J, Cruz-Rivera M, Hoag JE (2000) Budesonide inhalation suspension is chemically compatible with other nebulizing formulations. Chest 118(4) 98S... [Pg.261]

Inhaled corticosteroids Pulmicort respules (AstraZeneca) Budesonide Inhalation suspension 0.25 mg/2 mL, 0.5 mg/2 mL. In single-dose envelopes EDTA... [Pg.234]

Irani AM, Cruz-Rivera M, Fitzpatrick S, Hoag J, Smith JA. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma. Ann Allergy Asthma Immunol 2002 88(3) 306-12. [Pg.88]

Volovitz B, Nussinovitch M. Effect of high starting dose of budesonide inhalation suspension on serum cortisol concentration in young children with recurrent wheezing episodes. J Asthma 2003 40 625-9. [Pg.90]

Thorsson, L. Newman, S.P. Weisz, A. Trofast, E. Moren, F. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology 1993, 31, 7-10. [Pg.3105]

Hvizdos KM, Jarvis B. Budesonid inhalation suspension a review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs 60(5) 1141-1178, 2000. [Pg.580]

Shapiro G, et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol 102(5) 789-796, 1998. [Pg.580]

Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 104(4 Pt 2) 200-209, 1999. [Pg.580]

Newman S, Brown J, Steed K, Reader S, Kladders H. Lung deposition of budesonide inhaled via Turbuhaler a comparison with Terbutaline sulphate in normal subjects. Eur Respir, J 1998, 7, 69-73. [Pg.602]

Santolicandro A, Di Mauro M, Storti S, et al. Lung deposition of budesonide inhaled through Turbuhaler in asthmatic patients before and after bronchodilatation. Am J Respir Crit Care Med 1994 149(suppl) A220. [Pg.448]

Pulmicort Turbuhaler 200 meg (budesonide inhalation powder), AstraZeneca LP, in Physicians Desk Reference , 58 Edition, Thomson PDR, Montvale, NJ (2004) 642. [Pg.94]

Dahlstrom K, Larsson P. Lung deposition and systemic availability of budesonide inhaled as nebulized suspension from different nebulizers (abstr). Am JRespir Crit Care Med 1996 153 A339. [Pg.223]

See other pages where Budesonide inhaler is mentioned: [Pg.94]    [Pg.72]    [Pg.76]    [Pg.80]    [Pg.57]    [Pg.77]    [Pg.960]    [Pg.963]    [Pg.967]    [Pg.2889]    [Pg.159]    [Pg.411]   
See also in sourсe #XX -- [ Pg.94 ]



SEARCH



© 2024 chempedia.info